6869

SYSMEX CORPORATION

シスメックス株式会社
Healthcare · Medical Devices
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
← Companies
Price
¥1,397
Market Cap
¥877.5B
Ent. Value
¥820.3B
Net Cash
¥57.2B
Shares Out.
628.1M
P / E
16.2×
EV / EBIT
9.4×
P / Book
P / NCAV
5.35×
Div. Yield
2.29%
Financials
Metric FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Net Sales ¥508.6B ¥461.5B ¥410.5B ¥363.8B
Cost of Sales ¥236.7B ¥219.0B ¥194.4B ¥173.2B
Gross Profit ¥272.0B ¥242.5B ¥216.1B ¥190.6B
SG&A ¥150.8B ¥133.8B ¥112.4B ¥94.2B
Operating Income ¥87.6B ¥78.4B ¥73.7B ¥67.4B
Non-Operating Income ¥1.1B ¥937M ¥863M ¥550M
Non-Operating Expenses ¥3.5B ¥2.4B ¥1.6B ¥909M
Pre-tax Income ¥79.2B ¥74.6B ¥68.7B ¥64.3B
Net Income (owners) ¥53.7B ¥49.6B ¥45.8B ¥44.1B
Minority Interest ¥-93M ¥135M ¥-59M ¥-21M
Comprehensive Income ¥49.4B ¥73.4B ¥55.6B ¥56.4B
EBITDA ¥126.6B ¥114.3B ¥105.5B ¥94.8B
EPS ¥86.07 ¥79.27 ¥218.83 ¥210.88
Shares Outstanding 628.1M 209.3M 209.2M 209.2M
Shares Issued (total) 629.5M 209.8M 209.7M 209.7M
Treasury Shares 1.3M 0.4M 0.4M 0.4M